JPRN-UMIN000010765已完成2 期
Additive effect of zoledronic acid on hormone-sensitive prostate cancer patients with bone metastasis treated by hormonal therapy: a prospective, multicenter study - Additive effect of zoledronic acid on hormone-sensitive prostate cancer patients with bone metastasis treated by hormonal therapy: a prospective, multicenter study
Department of Urology, Saitama Medical Center, Saitama Medical University0 个研究点目标入组 100 人开始时间: 2013年5月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patients 1) do not meet the inclusion criteria. 2) have an allergy to bisphosphonates including zoledronic acid. 3) required an urgent radiation therapy for bone metastasis based on symptoms described below: unmanageable pain, spinal cord paralysis, etc. 4) have a treatment history with a bisphosphonate (excluding bisphosphonates taken orally). 5) have an uncontrollable pleural or pericardial effusion. 6) have a brain metastasis with symptoms. 7) have a heavy infection. 8) under or planned an invasive dental treatment. 9) have an interstitial pneumonitis or pulmonary fibrosis. 10) have an active cancer except prostate cancer: cancer free duration <= 3 years. 11) have a myocardial infarction within 6 months. 12) have severe complications: cardiovascular disease, hepatic dysfunction, or coagulation disorders, etc. 13) have mental disorders or neurological symptoms. 14) disqualified by a doctor in charge.
研究者
相似试验
尚未招募
2 期
Effect of Zoledronic acid for Stage D2 hormone-sensitive prostate cancer patients.Prostate CancerJPRN-UMIN000002577Department of Urology, Keio University School of Medicine96
已完成
不适用
A clinical trial to study the preventive effect of zoledronic acid therapy on drug induced bone loss in breast cancerCTRI/2014/09/004943Dr Ved Prakash20
进行中(未招募)
2 期
Does zoledronic acid alter levels of reproductive hormones and how does this affect the tumour and bone in pre- and post-menopausal women with early breast cancer?Breast CancerCancerISRCTN15749696Sheffield Teaching Hospitals NHS Foundation Trust19
进行中(未招募)
4 期
The effect of zolendronic acid on the clinical resolution of acute midfoot Charcot footCharcot neuroarthropathy in patients with diabetes mellitusMusculoskeletal - Other muscular and skeletal disordersMetabolic and Endocrine - DiabetesACTRN12611000065998Pirkanmaa Hospital District40
尚未招募
不适用
Efficacy of zoledronic acid hydrate on glucocorticoids-induced osteoporosis for patients with autoimmune hepatitisAutoimmune hepatitisJPRN-UMIN000031353Hyogo college of medicine40
